Tuesday, February 3, 2015

Pfizer Breast Cancer Drug Ibrance Approved for Sale

The Food and Drug Administration granted Pfizer’s Ibrance accelerated approval to treat advanced breast cancer.



from WSJ.com: US Business http://ift.tt/18LRVHS

via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)